Pannex Therapeutics
Anti-addictive painkillers to save lives.
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- pannextherapeutics.com
- Total Funding
- $250K
About
Pannex Therapeutics is a preclinical-stage biopharmaceutical company developing a novel class of Pannexin 1 (Panx1) channel blockers for chronic pain treatment and opioid addiction prevention. The company's first-in-class small molecule platform targets a new pharmacological pathway with potential applications across multiple neurological disorders and cancer. Based in New York with roots in Chile.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account